menu

Medical Industry Feature: Urothelial Carcinoma: Case Study on a Patient Who Is Platinum Ineligible

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
BD

Urothelial Carcinoma: Case Study on a Patient Who Is Platinum Ineligible

Urothelial Carcinoma: Case Study on a Patient Who Is Platinum Ineligible
RestartResume

What clues from a patient with urothelial carcinoma might indicate that platinum-based chemotherapy isn't a suitable option?

  • Sponsored by

  • Overview

    Determining if a patient with urothelial carcinoma is ineligible for platinum-based chemotherapy isn’t always easy. That’s why Dr. Peter O’Donnell, Associate Professor of Medicine in the Department of Medicine at the University of Chicago, reviews a hypothetical patient case that demonstrates how he comes to that conclusion.

    US-OBD-00541 08/20

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 10/25/20